Navigation Links
Response Genetics Announces Publication of a Phase III Clinical,Trial Demonstrating That Low Levels of ERCC-1 Help to Predict,Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer

- First prospective biomarker trial in non-small cell lung cancer -

LOS ANGELES, July 09, 2007 /PRNewswire-FirstCall/ -- Response Genetics, Inc. today announced that positive Phase III clinical data published in the July 1 issue of the Journal of Clinical Oncology suggests that low expression of the biomarker Excision-Repair Cross-Complementing 1 (ERCC-1) in patient biopsies with advanced non-small cell lung cancer (NSCLC) predicts for sensitivity to cisplatin-based chemotherapy. ERCC-1 is an enzyme involved in repair of DNA strand breaks such as those caused by cisplatin. The analysis of ERCC-1 levels in this study was conducted by Response Genetics using its RGI-1 technology. Data from previous studies published by the Company in Clinical Cancer Research 2002 and Annals of Oncology 2006 showing that ERCC-1 was associated with tumor sensitivity to cisplatin formed the basis for the present study. This is the first prospective study using a biomarker to predict chemotherapy response in lung cancer. These findings support the use of measurement of ERCC-1 for individualizing therapies for lung cancer patients.

The Phase III multicenter, randomized study was designed to determine the overall response rate (complete plus partial responses) of patients with stage IIIb or IV NSCLC to cisplatin-based therapy by determining levels of the biomarker ERCC-1 mRNA in their paraffin-embedded tissue biopsy before administering treatment. Patients were prospectively assigned treatment to a cisplatin or non-cisplatin-based chemotherapy depending on whether the ERCC-1 gene expression in their tumor sample was above or below a specific threshold. Patients were assigned to one of two arms in this trial. The control arm consisted of all patients receiving cisplatin-based therapy. Patients in the "genotypic" arm were separated by levels of ERCC-1. Cisplatin-based therapy (docetaxel/cisplatin) was assigned to patients with low
'"/>




Page: 1 2 3 4

Related medicine technology :

1. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
2. Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks
3. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
4. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
5. Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)
6. Introgen Reports Updated Phase 2 Advexin Data Correlating Improved Survival, Tumor Responses and Predictive p53 Biomarker
7. Dasatinib Shows High Early Response Rate as First Treatment for Chronic Myelogenous Leukemia, M. D. Anderson Researchers Report
8. Inovio Biomedicals DNA Delivery Technology Shows Safety and Enhances Gene Expression & Tumor Responses in Interim Melanoma Clinical Study Results
9. CEL-SCIS CEL-1000 Shown to Significantly Enhance Immune Response Against Avian Flu Antigen in Animals
10. VGX Pharmaceuticals Novel HIV and Pandemic Influenza DNA Vaccine Candidates Trigger Robust Immune Responses and Protection in Pre-Clinical Models
11. Vicals Vaxfectin Adjuvant With Needle-free Delivery Enhances DNA Vaccine Performance; Yields Antibody Responses Comparable to Electroporation Without Tolerability Issues
Post Your Comments:
(Date:7/23/2014)... July 23, 2014 ... Arbeiten für Sadara Chemical Company (Sadara) erhalten ... System innerhalb des integrierten Chemiekomplexes von Sadara ... additional scope im Wert von mehreren Millionen ... Vertrags dar, dessen Wert sich ebenfalls auf ...
(Date:7/22/2014)... /PRNewswire-iReach/ -- The global digital X-ray market is ... product, end user, price, and geography. The mammography ... rate in the digital X-ray market by application, ... attributed to technological advancements and the rising incidences ... largest share of the digital X-ray market, by ...
(Date:7/22/2014)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today ... financial results on Tuesday, August 5, 2014, after the ... a live audio webcast immediately following the announcement at ... and financial update and discuss second quarter 2014 financial ... audio webcast via the Investors & Media section of ...
Breaking Medicine Technology:Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 2Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 3Rolta gewinnt Follow-on Award für Engineering Systems für Sadara, Saudi-Arabien im Wert von mehreren Millionen Dollar 4Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com 2Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com 3Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com 4Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at RnRMarketResearch.com 5Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014 2
... -- ShangPharma Corporation (NYSE: SHP ) ("ShangPharma" or ... development outsourcing company, today announced that it will release its ... 31, 2011 on May 19, 2011. Management will host a ... Time on May 19, 2011 (8:00pm Beijing time on May ...
... NANJING, China, May 9, 2011 /PRNewswire-Asia/ -- Simcere ... SCR ), a leading pharmaceutical company specializing ... and proprietary pharmaceuticals in China, today announced that ... in which it holds a 35% equity interest, ...
Cached Medicine Technology:ShangPharma Corporation to Announce First Quarter 2011 Financial Results on May 19, 2011 2Simcere Announces Recent Progress of Qiangke's Registration 2
(Date:7/23/2014)... (PRWEB) July 23, 2014 On July 4th, at ... in Naperville, Illinois, took a first place prize in her age ... a self-professed late-bloomer. She waited until she was in her forties ... 65, she decided to start running. Not one to do anything ... , For Kitty, the decision to begin running started ...
(Date:7/22/2014)... Print Audit® has released another ... web portal. Facilities Manager 3.1.0R includes fixes for ... as well as numerous new reporting and alerting ... Manager is a powerful, easy to use managed ... reads, automate supplies fulfillment and report service information ...
(Date:7/22/2014)... OK (PRWEB) July 22, 2014 ... launch of the newest component of its existing telemedicine ... hospital within the regional SSM Health Care of Oklahoma ... health centers that shares its services with an even ... care centers across several states. As a forward-thinking organization ...
(Date:7/22/2014)... It all started as a meeting of souls from ... Willem de Liefde wanted to help family, friends and colleagues ... , Willem wrote The Ego’s Echo for those who are ... things. It is an invitation to go on a continuing ... This book represents a breakthrough in the quest for individual ...
(Date:7/22/2014)... CA (PRWEB) July 22, 2014 Mona ... instructor certification on August 15th & 16th, 2014, at ... industry's only structured and nationally accredited Bollywood workout was ... Powered by the globally appealing Bollywood culture, Bombay Jam® ... safe, easy to follow and designed with authentic Bollywood ...
Breaking Medicine News(10 mins):Health News:Naperville, Ilinois’ Monarch Landing Resident Wins First Place in 5K Run 2Health News:Print Audit® Releases Facilities Manager 3.1.0R 2Health News:St. Anthony Hospital Expands Its Telemedicine Program with Telepsychiatry 2Health News:St. Anthony Hospital Expands Its Telemedicine Program with Telepsychiatry 3Health News:Willem de Liefde, Author and Management Expert, Releases New Guide for Understanding Friends, Family, Co-Workers and Ourselves 2Health News:Mona Khan Company Announces Bombay Jam® Instructor Certification in Los Angeles in August 2014 2Health News:Mona Khan Company Announces Bombay Jam® Instructor Certification in Los Angeles in August 2014 3
... Solutions study outlines plan to help,primary care doctors ... Feb. 6 Primary care physicians,should exert broader ... compensated accordingly for their enhanced role in overall ... for Health Solutions,( http://www.deloitte.com/centerforhealthsolutions ) concludes., In ...
... Health Stewardship Project to release health care,reform ... WASHINGTON, Feb. 6 The Aspen ... care reform,principles that will enrich the health ... the proposed policies as candidates and policymakers ...
... BIRMINGHAM, Ala., Feb. 6 Emageon Inc.,(Nasdaq: ... technology,systems for hospitals, healthcare networks and imaging facilities, ... quarter and full year,2007 financial results on Thursday, ... company anticipates that these results will be available ...
... Coincides With National and Local News on these Issues, ... got a call from the police that her husband had ... own, she knew she had to,take action. Her husband, LaVern, ... Alzheimer,s disease in 2004, but this time the,situation had really ...
... UC Davis Collaboration, RANCHO CORDOVA, Calif., Feb. ... leading supplier of innovative products and,services that process ... disease,and injury, today announced a regenerative medicine initiative ... a wholly-owned subsidiary, Vantus, Inc., a,veterinary stem cell ...
... of multiple risk factors at once, , , WEDNESDAY, Feb. ... are already showing signs of some kidney damage may be ... multiple risk factors at once. , That,s the conclusion ... issue of the New England Journal of Medicine , ...
Cached Medicine News:Health News:The Medical Home: Building a Framework of Higher Quality, Reduced Cost and Patient-Centric Care 2Health News:The Medical Home: Building a Framework of Higher Quality, Reduced Cost and Patient-Centric Care 3Health News:Access Is Not Enough: What It Will Take to Transform Health Care in the United States 2Health News:Emageon Inc. to Host Fourth Quarter 2007 Financial Results Conference Call February 21, 2008 2Health News:Caregiver Magazine Urges Preventive Measures Against Wandering, Falls, Abuse 2Health News:Caregiver Magazine Urges Preventive Measures Against Wandering, Falls, Abuse 3Health News:Thermogenesis Announces New Initiative to Address Veterinary Regenerative Medicine 2Health News:Thermogenesis Announces New Initiative to Address Veterinary Regenerative Medicine 3Health News:Thermogenesis Announces New Initiative to Address Veterinary Regenerative Medicine 4Health News:Aggressive Diabetes Therapy Lowers Death Risk, Study Finds 2Health News:Aggressive Diabetes Therapy Lowers Death Risk, Study Finds 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: